Early Taurine Administration Decreases the Levels of Receptor-Interacting Serine/Threonine Protein Kinase 1 in the Duchenne Mouse Model mdx
Open Access
- 30 October 2025
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 15 (11) , 1175
Abstract
Background/Objectives: The progressive life-limiting disorder Duchenne muscular dystrophy (DMD) arises from the absence of dystrophin protein at the muscle cell membrane, which leads to progressive contraction-induced damage. Despite the advancements in molecular therapies aimed at reintroducing (partially functional) dystrophin in patients, a cure for DMD remains elusive. Taurine supplements have been proposed as a potential supportive treatment for DMD, based upon encouraging results in the mouse model mdx. Methods: In a previous study, we observed improvements in skeletal muscle histology and a reduction in the expression of inflammatory markers after short-term treatment with 4.6 g taurine per kg body weight during the initial stages of the disease. In this follow-up study, we examined cell death and tissue restoration protein levels in mdx subjected to the same treatment regimen, utilizing proteome arrays, Western blotting, and immunofluorescence. Results: We report that, while the levels of apoptotic and autophagic proteins remained constant, selective and significant decrease in receptor-interacting Serine/Threonine protein kinase 1 (RIP1) levels could be observed in taurine-treated mdx compared to untreated mdx. RIP1 was immunolocalized to muscle fibers, with faint homogeneous staining in age-matched healthy controls shifting to a heterogeneous staining pattern in mdx, the latter diminishing with taurine treatment. Conclusions: Given its role as a molecular switch in cell fate decisions, the observed taurine-induced downregulation of RIP1 supports the potential beneficial effects of the osmolyte in mdx.Keywords
Funding Information
- Association Belge contre les Maladies neuro-Musculaires ASBL (ABMM) aide à la recherche
This publication has 77 references indexed in Scilit:
- Taurine rescues intervertebral disc degeneration by activating mitophagy through the PINK1/Parkin pathwayBiochemical and Biophysical Research Communications, 2024
- Receptor interacting protein kinase‐3 mediates both myopathy and cardiomyopathy in preclinical animal models of Duchenne muscular dystrophyJournal of Cachexia, Sarcopenia and Muscle, 2023
- Taurine alleviates ochratoxin A‐induced pyroptosis in PK‐15 cells by inhibiting oxidative stressJournal of Biochemical and Molecular Toxicology, 2022
- Down-regulation of pro-necroptotic molecules blunts necroptosis during myogenesisBiochemical and Biophysical Research Communications, 2021
- Taurine attenuates valproic acid-induced hepatotoxicity via modulation of RIPK1/RIPK3/MLKL-mediated necroptosis signaling in miceMolecular Biology Reports, 2021
- Attenuated Epigenetic Suppression of Muscle Stem Cell Necroptosis Is Required for Efficient Regeneration of Dystrophic MusclesCell Reports, 2020
- Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H2O2 emission during impaired oxidative phosphorylationJournal of Cachexia, Sarcopenia and Muscle, 2019
- Cell death-resistance of differentiated myotubes is associated with enhanced anti-apoptotic mechanisms compared to myoblastsApoptosis, 2010
- The Noncoding RNA Taurine Upregulated Gene 1 Is Required for Differentiation of the Murine RetinaCurrent Biology, 2005
- Fiber regeneration is not persistent in dystrophic (mdx) mouse skeletal muscleDevelopmental Biology, 1991